REBECCA REINHARD: Open Payments
NPI 1073100640 · PROSSER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 49 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $590 · 2025 $1,455
Food & beverage: $1,455
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $284 |
| Janssen Biotech, Inc. | 2 | $221 |
| Madrigal Pharmaceuticals | 7 | $208 |
| Ardelyx, Inc. | 3 | $157 |
| GENZYME CORPORATION | 1 | $95 |
| Lilly USA, LLC | 4 | $92 |
| ABBVIE INC. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Agios Pharmaceuticals, Inc. | 1 | $29 |
Products named: ENTYVIO, TREMFYA, REZDIFFRA, IBSRELA, DUPIXENT, OMVOH, RINVOQ, JARDIANCE.
Industry payments across WA — which companies pay providers there.
